Cancer & SURVIVEiT News
Category Filter:
FDA approves neratinib for metastatic HER2-positive breast cancer
FDA approves neratinib for metastatic HER2-positive breast cancer On February 25, 2020, the Food and Drug Administration approved neratinib (NERLYNX, Puma Biotechnology, Inc.) in combination with capecitabine for adult patients…
Regular Exercise Can Improve Quality of Life For Breast Cancer Patients
Researchers at the University of Alberta found that regular exercise, both during and after chemotherapy, can improve the quality of life as well as cancer-related symptoms in breast cancer patients.…
How To Perform a Male Breast Exam Self-Check | Male Breast Cancer Awareness
During Breast Cancer Awareness month, it’s important to spread the word about all types of breast cancer so everyone can be familiar with the signs…and that includes men too. Men…
Link To Rare Cancer Causes Breast Implants To Be Recalled
Breast Cancer Awareness month is about bringing awareness to all aspects of breast cancer, not only the symptoms. For some breast cancer patients and breast cancer survivors, breast implants, augmentation…
Real Thoughts That Cross A Breast Cancer Patient’s Mind
The emotions that come along with a cancer diagnosis can be a rollercoaster. A common feeling that many breast cancer patients experience is fear. During Breast Cancer Awareness month we…
FDA approves entrectinib for NTRK solid tumors and ROS-1 NSCLC
FDA approves entrectinib for NTRK solid tumors and ROS-1 NSCLC On August 15, 2019, the Food and Drug Administration granted accelerated approval to entrectinib (ROZLYTREK, Genentech Inc.) for adults and…
FDA approves Herzuma as a biosimilar to Herceptin (for breast cancer)
FDA approves Herzuma as a biosimilar to Herceptin On December 14, 2018, the Food and Drug Administration approved Herzuma (trastuzumab-pkrb, Celltrion Inc.) as a biosimilar to Herceptin (trastuzumab, Genentech Inc.)…
FDA approves talazoparib for gBRCAm HER2-negative locally advanced or metastatic breast cancer
FDA approves talazoparib for gBRCAm HER2-negative locally advanced or metastatic breast cancer On October 16, 2018, the Food and Drug Administration approved talazoparib (TALZENNA, Pfizer Inc.), a poly (ADP-ribose) polymerase…
Study shows value of breast cancer patients seeking second opinions
Study shows value of breast cancer patients seeking second opinions As scary as a cancer diagnosis can be, pausing to get more information can yield benefits Dawn Brazell | [email protected] | September 19,…
- « Previous
- 1
- 2